13F filer · CIK 1397144
Abingworth LLP
LONDON, X0 · filing since Q2 2013 · last filing Nov 6, 2026
Reported value
$306.9M
+$14.4M vs prior
Positions
19
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $103.1M
Top-10 weight
96.9%
Biggest buys vs Q3 2022
No new or increased positions this quarter.
Biggest sells vs Q3 2022
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | VAXCYTE INC | -2,149,661 | -51.6% | $-103.1M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2022
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | VAXCYTE INCCOM | 2,019,057 | $96.8M | 31.54% |
| 2 | VERONA PHARMA PLCSPONSORED ADS | 2,457,500 | $64.2M | 20.92% |
| 3 | VERA THERAPEUTICS INCCL A | 2,960,231 | $57.3M | 18.66% |
| 4 | HILLEVAX INCCOM | 1,838,486 | $30.8M | 10.02% |
| 5 | ADICET BIO INCCOM | 2,115,385 | $18.9M | 6.16% |
| 6 | PHATHOM PHARMACEUTICALS INCCOM | 1,435,106 | $16.1M | 5.25% |
| 7 | RENEO PHARMACEUTICALS INCCOM | 2,073,957 | $4.8M | 1.57% |
| 8 | SIENTRA INCCOM | 1,673,589 | $3.4M | 1.11% |
| 9 | JASPER THERAPEUTICS INCCOM | 5,628,558 | $2.7M | 0.89% |
| 10 | SOLENO THERAPEUTICS INCCOM | 1,201,506 | $2.4M | 0.78% |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.